Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,443,981
+$207,734 QoQ
Shares Held
65,015
-4.7% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#108
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,518 across 427 Biotechnology names. DYN ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,443,981 | 65,015 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,236,247 | 68,188 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $362,778 | 18,547 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,871,048 | 543,166 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,569,704 | 374,969 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $7,687 | 735 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $49,874 | 2,117 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $348,672 | 9,707 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $285,425 | 8,088 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $142,488 | 5,019 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $191,970 | 14,434 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $71,768 | 8,010 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $57,126 | 5,078 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,844 | 2,938 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $54,866 | 4,734 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,672 | 1,549 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,211 | 1,341 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $29,006 | 3,009 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $88,437 | 7,438 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $80,322 | 4,946 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $43,342 | 2,060 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $23,946 | 1,542 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $13,776 | 656 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||